36 studies found for:    " August 22, 2012":" September 21, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations
Condition: HIV Infection
Intervention: Behavioral: Integrated care centers
22 Terminated Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Conditions: HIV Infection;   Malaria
Intervention: Drug: Artemether/Lumefantrine (AL)
23 Completed Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
Condition: HIV
Interventions: Drug: Tenofovir;   Drug: Zidovudine
24 Completed Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Conditions: Circumcision Adult;   HIV CDC Category B2
Intervention: Device: PrePex™ device
25 Completed Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)
Condition: HIV-1 Infection
Interventions: Drug: Part A: lenalidomide dose escalation;   Drug: Part B: lenalidomide;   Drug: Part B: lenalidomide placebo
26 Active, not recruiting Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)
Condition: HIV
Intervention: Other: Rapid ART initiation
27 Unknown  A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
28 Recruiting Rifampin and Nevirapine Interactions in Young Children
Conditions: Tuberculosis;   HIV
Intervention:
29 Completed Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
30 Unknown  A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study
Condition: HIV
Intervention: Drug: maraviroc
31 Recruiting Pilot Study of Diflunisal in HIV-infected Adults
Condition: HIV Infection
Intervention: Drug: Diflunisal
32 Completed Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir
33 Recruiting Screening, Brief Intervention, and Referral to Treatment for Offenders
Conditions: Substance Use;   HIV Infections
Interventions: Behavioral: SBIRT;   Behavioral: Control Group
34 Not yet recruiting Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
35 Not yet recruiting Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
36 Recruiting Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
Conditions: Sexually Transmitted Diseases;   Unsafe Sex;   Substance-Related Disorders
Interventions: Behavioral: PACT;   Behavioral: TAU

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years